Norman Hardman

Norman Hardman currently works at Oxalis Partners LLC, as President & Chief Executive Officer from 2006 and Anosos Biotherapeutics LLC, as Chief Executive Officer.
Dr. Hardman also formerly worked at Amicus Therapeutics, Inc., as President & Chief Executive Officer from 2002 to 2004, Lifearc, as Chief Executive Officer from 2002 to 2003, ValiRx Plc, as Non-Executive Director, Chelsea Therapeutics International Ltd., as Independent Director from 2008 to 2012, Chelsea Therapeutics, Inc., as Director, AERES Biomedical Ltd., as Director, Enzon Pharmaceuticals, Inc., as Senior Vice President-Technology in 2003, gMed., Inc., as President & Chief Operating Officer, Onyx Pharmaceuticals, Inc., as Chief Operating Officer, Novartis AG, as Head-UK Research & Development Operations, and BASF Performance Products Ltd. (United Kingdom), as Head-Research & Development.
Dr. Hardman received his doctorate degree from The University of Manchester and undergraduate degree from the University of London.